CLINICAL AND DEMOGRAPHICS CHARACTERISTICS OF NON-VALVULAR ATRIAL FIBRILLATION PATIENTS SWITCHING FROM WARFARIN TO NOVEL ORAL ANTICOAGULANTS

被引：0
|
作者：
Kachroo, S. [1 ]
Pan, X. [2 ]
Liu, L. [3 ]
Kawabata, H. [4 ]
Phatak, H. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
[2] Bristol Myers Squibb Co, New Haven, CT USA
[3] Pfizer, New York, NY USA
[4] Bristol Myers Squibb, Hopewell, NJ USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.1506
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV161
引用
收藏
页码：A500 / A501
页数：2
相关论文
共 50 条
  • [1] Effect and risk of novel oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation
    Kawada, Tomoyuki
    [J]. JOURNAL OF CARDIOLOGY, 2017, 70 (1-2) : 99 - 99
  • [2] Novel oral anticoagulants in non-valvular atrial fibrillation
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 115 - 129
  • [3] Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims
    Lip, Gregory Y. H.
    Noxon, Virginia
    Kang, Amiee
    Luo, Xuemei
    Atreja, Nipun
    Han, Stella
    Cheng, Dong
    Jiang, Jenny
    Abramovitz, Lisa
    Deitelzweig, Steven
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (06) : 1092 - 1102
  • [4] Changing trends in the use of novel oral anticoagulants and warfarin for treating non-valvular atrial fibrillation
    Birkinshaw, Alexander
    Fry, Christopher H.
    Fluck, David
    Sharma, Pankaj
    Han, Thang S.
    [J]. JRSM CARDIOVASCULAR DISEASE, 2020, 9
  • [5] Novel Anticoagulants for Non-valvular Atrial Fibrillation
    Xu, Bo
    Whitbourn, Robert
    [J]. HEART LUNG AND CIRCULATION, 2012, 21 (08): : 463 - 467
  • [6] New oral anticoagulants in non-valvular atrial fibrillation
    Francia P.
    Adduci C.
    Santini D.
    Musumeci B.
    Tocci G.
    [J]. High Blood Pressure & Cardiovascular Prevention, 2013, 20 (2) : 53 - 60
  • [7] Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation
    Halperin, Jonathan L.
    Dorian, Paul
    [J]. CURRENT CARDIOLOGY REVIEWS, 2014, 10 (04) : 297 - 302
  • [8] Psychological effects of treatment with novel oral anticoagulants in non-valvular atrial fibrillation patients
    Oncel, Can Ramazan
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (05): : 364 - 364
  • [9] Oral anticoagulants in diabetic and nondiabetic patients with non-valvular atrial fibrillation
    Derosa, G.
    Raddino, R.
    Gavazzoni, M.
    Pasini, G.
    Gaudio, G.
    Maggi, A.
    D'Angelo, A.
    Ragonesi, P. D.
    Brunetti, N.
    De Gennaro, L.
    Cattaneo, M.
    Maffioli, P.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 1409 - 1409
  • [10] Choice of oral anticoagulants in older patients with non-valvular atrial fibrillation
    Jolobe, Oscar M. P.
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2017, 78 (07) : 416 - 416
12345